Given new research from Sweden, it won’t hurt—and might help—for clinicians to suggest their patients with attention deficit disorder (ADD) take supplements of the fatty acids omega 3 and 6.
School districts should move start times for middle and high schools to 8:30 a.m. or later, so that students can get at least 8.5 hours of sleep per night, according to the American Academy of Pediatrics.
More than a quarter-million middle school and high school students who had never smoked regular cigarettes used e-cigarettes in 2013, according to a study released by the US Centers for Disease Control and Prevention (CDC).
The psychiatric community continues to debate the value of the US Food and Drug Administration's (FDA) so-called ‘black box’ warning on certain antidepressants, and a pair of opposing viewpoints was recently featured in the New England Journal of Medicine.
The US Food and Drug Administration (FDA) last month approved Merck’s new insomnia drug, Belsomra, the first in a new class of hypnotics termed “orexin antagonists.” If you’ve never heard of orexin, put on your seat belts, because you’ll be getting a crash course from your local drug reps.
Naltrexone, which first hit the US market in 1984 as a treatment for alcohol dependence, continues to find new uses. Its latest incarnation, Contrave, was just approved by the Food and Drug Administration (FDA) in September as a weight loss medication.
Like most psychiatrists, you are likely a bit wary of sharing your therapy notes with your patients. Will they be offended by reading painfully honest descriptions of their issues? Will they be confused by your use of psychiatric terminology?
A new report from the Centers for Disease Control and Prevention (CDC) says that in adults ages 20 to 64, one in 10 deaths are the result of excessive drinking.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
